CACCIATORE, Ivana
 Distribuzione geografica
Continente #
NA - Nord America 7.119
EU - Europa 5.912
AS - Asia 4.931
SA - Sud America 521
AF - Africa 69
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 4
Totale 18.563
Nazione #
US - Stati Uniti d'America 6.964
SG - Singapore 2.025
CN - Cina 1.320
IT - Italia 1.295
RU - Federazione Russa 1.147
IE - Irlanda 679
UA - Ucraina 551
VN - Vietnam 531
SE - Svezia 502
GB - Regno Unito 487
TR - Turchia 419
BR - Brasile 413
DE - Germania 393
FR - Francia 388
IN - India 270
FI - Finlandia 168
HK - Hong Kong 94
CA - Canada 80
PL - Polonia 59
MX - Messico 51
BD - Bangladesh 50
JP - Giappone 44
AR - Argentina 41
AT - Austria 39
BE - Belgio 37
NL - Olanda 34
ES - Italia 30
IQ - Iraq 29
KR - Corea 24
CZ - Repubblica Ceca 23
ZA - Sudafrica 21
LT - Lituania 18
EC - Ecuador 17
GR - Grecia 16
IR - Iran 16
PK - Pakistan 16
ID - Indonesia 13
SA - Arabia Saudita 13
CO - Colombia 12
EG - Egitto 11
CH - Svizzera 10
MA - Marocco 10
IL - Israele 9
JO - Giordania 9
AE - Emirati Arabi Uniti 8
CL - Cile 8
KE - Kenya 8
VE - Venezuela 8
EU - Europa 7
PY - Paraguay 7
UZ - Uzbekistan 7
TN - Tunisia 6
AZ - Azerbaigian 5
DK - Danimarca 5
MY - Malesia 5
PE - Perù 5
PH - Filippine 5
PT - Portogallo 5
UY - Uruguay 5
CR - Costa Rica 4
JM - Giamaica 4
NO - Norvegia 4
NP - Nepal 4
PA - Panama 4
RO - Romania 4
AU - Australia 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
EE - Estonia 3
KW - Kuwait 3
LB - Libano 3
TT - Trinidad e Tobago 3
AL - Albania 2
BG - Bulgaria 2
BO - Bolivia 2
BY - Bielorussia 2
CG - Congo 2
CI - Costa d'Avorio 2
GY - Guiana 2
HN - Honduras 2
HU - Ungheria 2
KZ - Kazakistan 2
NI - Nicaragua 2
RS - Serbia 2
TW - Taiwan 2
AO - Angola 1
BH - Bahrain 1
BN - Brunei Darussalam 1
ET - Etiopia 1
GA - Gabon 1
GD - Grenada 1
GT - Guatemala 1
HR - Croazia 1
LK - Sri Lanka 1
LV - Lettonia 1
ME - Montenegro 1
MR - Mauritania 1
MT - Malta 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
Totale 18.558
Città #
Singapore 1.549
Chandler 880
San Jose 717
Dublin 671
Jacksonville 647
Ashburn 499
Dallas 347
Beijing 322
Southend 300
Princeton 272
Chieti 254
Izmir 219
Nanjing 193
Los Angeles 186
New York 179
Ho Chi Minh City 169
The Dalles 164
Santa Clara 160
Dearborn 151
Ann Arbor 147
Munich 138
Wilmington 122
Hanoi 115
Pescara 110
Cambridge 98
Altamura 94
Tongling 88
Hong Kong 81
Boardman 72
Buffalo 67
Rome 67
Nanchang 64
Moscow 63
Council Bluffs 55
Shenyang 50
São Paulo 44
Dong Ket 43
Helsinki 42
Warsaw 42
Hefei 41
Tokyo 41
Tianjin 40
Frankfurt am Main 39
Kunming 39
Redondo Beach 39
Woodbridge 39
Denver 37
Orem 34
Brussels 33
Milan 33
Hebei 32
Seattle 29
Chennai 28
Chicago 28
Jinan 28
Da Nang 26
Falls Church 26
Houston 26
London 25
Toronto 25
Montreal 24
Nuremberg 24
Turku 24
Vienna 24
Washington 24
Zhengzhou 23
Manchester 22
Mexico City 22
Atlanta 21
Boston 21
Jiaxing 21
Norwalk 21
Seoul 21
Poplar 20
Brooklyn 19
Brno 18
Grevenbroich 18
Haiphong 18
Augusta 17
Kocaeli 17
Stockholm 17
Changsha 16
Guangzhou 16
Johannesburg 16
San Francisco 15
Amsterdam 14
Ancona 14
Brasília 14
Ankara 13
Leawood 13
Ningbo 13
Silvi 13
Teramo 13
Hangzhou 12
Naples 12
Bologna 11
Rio de Janeiro 11
Romola 11
Roubaix 11
Shanghai 11
Totale 10.854
Nome #
A new chromogenic substrate for pantetheine hydrolase and vanin proteins 768
Il cofarmaco ibuprofene-glutatione quale nuovo potenziale agente anti-alzheimer 394
Chelating and antioxidant properties of l-Dopa containing tetrapeptide for the treatment of neurodegenerative diseases 201
Development of glycine-α-methyl-proline-containing tripeptides with neuroprotective properties 199
(R)-α-Lipoyl-glycyl-L-prolyl-L-glutamyl dimethyl ester codrug as a multifunctional agent with potential neuroprotective activities 191
Modulation of apoptotic cell death and neuroprotective effects of glutathione—L-Dopa codrug against H2O2-induced cellular toxicity 184
Preparation of boronate derivatives for the treatment of diseases and conditions associated to oxidative stress 183
Carvacrol reduces adipogenic differentiation by modulating autophagy and ChREBP expression 181
Gold nanoparticles as scaffolds for poor water soluble and difficult to vehiculate antiparkinson codrugs 178
(R)-α-Lipoyl-Gly-L-Pro-L-Glu dimethyl ester as dual acting agent for the treatment of Alzheimer's disease 171
A glutathione derivative with chelating and in vitro neuroprotective activities: synthesis, physicochemical properties, and biological evaluation. 169
2,5-Diketopiperazines as neuroprotective agents 167
Memantine-derived drugs as potential antitumor agents for the treatment of glioblastoma 164
Synthesis of a novel cyclic prodrug of S -allyl-glutathione able to attenuate LPS-induced ROS production through the inhibition of MAPK pathways in U937 cells 163
Solid lipid nanoparticles loaded with lipoyl-memantine codrug: preparation and characterization 159
NSAID Coniugates for the treatment of Alzheimer's Disease 158
Sintesi e valutazione dell’attività antimicrobica di nuovi carvacrolo codrugs 156
Toxicity assessment of hydroxyapatite nanoparticles in rat liver cell model in vitro 156
Carvacrol prodrugs as novel antimicrobial agents 156
A Potent (R)-alpha-bis-lipoyl Derivative Containing 8-Hydroxyquinoline Scaffold: Synthesis and Biological Evaluation of Its Neuroprotective Capabilities in SH-SY5Y Human Neuroblastoma Cells 155
Carvacrol codrugs: A new approach in the antimicrobial plan 155
Ibuprofen and glutathione conjugate as a potential therapeutic agent for treating Alzheimer's disease 154
Synthesis of a novel TRH-related sulphonamido peptide 153
CNS delivery of L-Dopa by a new Hybrid Glutathione-Methionine peptidomimetic prodrug 153
Preparation and characterization of polymeric micelles loaded with a potential anticancer prodrug 153
Advances in prodrug design for Parkinson's disease 153
(R)-alpha-Lipoic Acid–Gly-L-Pro-L-Glu(OMe)-OMe Codrug as Multifunctional Agent for Neurodegenerative Diseases, with Antioxidant and Neuroprotective Properties 152
Effect of MRJF4 on C6 glioma cells proliferation and migration 151
N-Acetyl-L-Methionyl-L-Dopa-Methyl Ester as a dual acting drug that relieves L-Dopa-induced oxidative toxicity 149
GPE and GPE analogues as promising neuroprotective agents 147
Synthesis and preliminary pharmacological evaluation of 2,3,4,8,13a-hexahydro-1H-benzo(5,6)cyclohepta(1,2,3-ef)(3)benzazepine-6,7-diol derivatives as dopamine receptor ligands 146
Carvacrol and its derivatives as antibacterial agents 146
Cofarmaci L-Dopa-antiossidanti solforati quali nuovi potenziali agenti anti-Parkinson 145
Novel NSAID-derived drugs for the potential treatment of Alzheimer’s disease 143
Synthesis and Biological Evaluation of Novel Selenyl and Sulfur-l-Dopa Derivatives as Potential Anti-Parkinson's Disease Agents 142
Synthesis and evaluation of trans-2-amino-5(or 6)-chloro-6(or 5)-hydroxy-1-phenyl-2,3-dihydro-1H-indenes as dopamine receptor ligands 141
Sintesi di trans-2-ammino-5(o 6)-cloro-6(o 5)-idrossi-1-fenil-2,3-diidro-1H-indani quali precursori di derivati a potenziale affinità per i recettori della dopamina 141
New pharmacologic tools against Parkinson's disease: L-Dopa-antioxidant codrugs containing the methionine residue 140
Resveratrol Derivative Exhibits Marked Antiproliferative Actions, Affecting Stemness in Pancreatic Cancer Cells 139
Biochemical properties of new synthetic carnosine analogues containing the residue of 2,3-diaminopropionic acid: the effect of N-acetylation 139
Viscoelastic behaviour of hyaluronic acid formulations containing carvacrol prodrugs with antibacterial properties 139
Synthesis and antioxidant properties of novel memantine derivatives 139
Synthesis of Short Cationic Antimicrobial Peptidomimetics Containing Arginine Analogs 138
Synthesis and biological evaluation of novel analogues of Gly-l-Pro-l-Glu (GPE) as neuroprotective agents 138
Emerging Effects of Resveratrol Derivatives in Cells Involved in Oral Wound Healing: A Preliminary Study 136
Evaluation of 2,3,4,8,13a hexahydro-1H-Benzo[5,6]cyclohepta-6,7-dihydroxy[1,2,3-ef][3]benzazepine derivatives as dopamine receptor ligands 136
L-dopa co-drugs in nanostructured lipid carriers: A comparative study 136
Sintesi di trans-2-ammino-1-fenil-5-fluoro-6-idrossi (e 6-fluoro-5-idrossi)-2,3-diidro-1H-indeni quali potenziali ligandi per i recettori dopaminergici 135
sintesi ed attività di due analoghi del glutatione a conformazione ristretta 134
N-(tert-butilossicarbonil)-beta,beta-ciclopentil-cisteina (acetamidometil)-metil estere per la sintesi di nuovi derivati peptidomimetici 133
Synthesis and Study of L-Dopa-Glutathione Codrugs as New Anti-Parkinson Agents with Free Radical Scavenging Properties. 131
Codrugs Linking l-Dopa and Sulfur-Containing Antioxidants: New Pharmacological Tools against Parkinson’s Disease 131
N-(tert)-Butyloxycarbonyl-beta,beta-Cyclopentyl-Cysteine (Acetamidomethyl)-Methyl Ester for Synthesis of Novel Peptidomimetic Derivatives 130
Discovery of novel RIP derivatives by alanine scanning for the treatment of S. aureus infections. 129
synthesis and Activity of L-Dopa-Thiol antioxidant Co-drugs and New anti-PArkinson Agents with free Radical Scavenging Properties 128
Synthesis, characterization and evaluation of gemfibrozil-stilbene hybrid as antioxidant agent 127
Solid lipid nanoparticles as a drug delivery system for the treatment of neurodegenerative diseases 127
Nanoencapsulation strategies for the delivery of novel bifunctional antioxidant/σ1 selective ligands 126
RNAIII Inhibiting Peptide (RIP) and derivatives as potential tools for the treatment of S. aureus biofilm infections 126
Synthesis and evaluation of new endomorphoin analogues modified at the Pro2 residue 125
Memantine-sulphur containing antioxidant conjugates as potential prodrugs to improve the treatment of Alzheimer’s disease 125
Novel anti-Alzheimer phenol-lipoyl hybrids: Synthesis, physico-chemical characterization, and biological evaluation 125
Anticancer effects of novel NSAIDs derivatives on cultured human glioblastoma cells 125
Delivery Methods of Camptothecin and Its Hydrosoluble Analogue Irinotecan for Treatment of Colorectal Cancer 124
Synthesis and activity of fluorescent glutathione S-conjugates as novel GST inhibitors 123
Synthesis and preliminary pharmacological evaluation of trans-2-amino-5(6)-chloro-6(5)-hydroxy-1- phenyl-2,3-dihydro-1H-indenes as dopamine receptor ligands 123
Nano-delivery systems based on carvacrol prodrugs and fibrous clays 123
Direct- and spacer-coupled codrug strategies for the treatment of Alzheimer’s disease 122
Multiple lipid nanoparticles as antimicrobial drug delivery systems 122
synthesis and biological evaluation as anti-Parkinson agent of an analogue of Glutathione-L-Dopa containing methionine in place of the cysteinil residue 121
Preparation and pharmacological characterization of trans-2-amino-5(6)-fluoro-6(5)-hydroxy-1-phenyl-2,3-dihydro-1H-indenes as D2-like dopamine receptor agonists 121
Synthesis and biological evaluation of a novel pyroglutamil-modified TRH analogue 118
Nuovi S-coniugati del glutatione ad attività inibitoria nei confronti delle GST umane 118
Antifungal Activity of Novel Formulations Based on Terpenoid Prodrugs against C. albicans in a Mouse Model 118
Anti-Obesity and Anti-Inflammatory Effects of Novel Carvacrol Derivatives on 3T3-L1 and WJ-MSCs Cells 117
Cytotoxicity and genotoxicity of iron oxide nanoparticles: An in vitro biosafety study 116
Hepatic effects of yttrium oxide nanoflowers: in vitro risk evaluation 116
In Vitro Wound-Healing Properties of Water-Soluble Terpenoids Loaded on Halloysite Clay 116
Development of l-Dopa-containing diketopiperazines as blood-brain barrier shuttle 115
Structure-Activity relationships of biphalin analogs and their biological evaluation on opioid receptors 115
Potent isozyme-selective inhibition of human glutathione S-transferase A1-1 by a novel glutathione S-conjugate 115
Facile transformation of glutamic acid into proline residue inside a tripeptide backbone 114
Synthesis and Biological Evaluation of Novel Cinnamic Acid-Based Antimicrobials 114
Dimeric L-dopa derivatives as potential prodrugs. 113
New bifunctional antioxidant/σ1 agonist ligands: Preliminary chemico-physical and biological evaluation 113
Carvacrol prodrugs with antimicrobial activity loaded on clay nanocomposites 113
Efficacy of the quorum sensing inhibitor FS10 alone and in combination with tigecycline in an animal model of staphylococcal infected wound. 113
Role of Dietary Supplements in the Management of Parkinson's Disease 112
Transition state isosteres of the gamma-glutamyl peptide bond hydrolysis: synthesis and characterization of the psi (CH2NH) pseudopeptide analogue of glutathione 112
Design, synthesis and evaluation of new endomorphin analogues incorporating constrained aminoacids in place of Pro2 residue 111
MRJF4, a novel histone deacetylase inhibitor, induces p21 mediated autophagy in PC3 prostate cancer cells 111
Neuroinflammation and endoplasmic reticulum stress are coregulated by cyclo(His-Pro) to prevent LPS neurotoxicity 110
Molecular mechanism undelying the cerebral effect of Gly-Pro-Glu tripeptide bound to L-dopa in a Parkinson's animal model 109
Synthesis of GPE analogues as potential neuroprotective agents 109
Natural oxyprenylated coumarins are modulators of melanogenesis 109
A Novel Prodrug of a nNOS Inhibitor with Improved Pharmacokinetic Potential 108
Synthesis and activity of endomorphin-2 and morphiceptin analogues with proline surrogates in position 2 107
Conformationally Constrained Histidines in the Design of Peptidomimetics: Strategies for the χ-Space Control 107
Quorum sensing inhibitor FS3-coated vascular graft enhances daptomycin efficacy in a rat model of staphylococcal infection 107
Proline-Glutamate Chimeras in Isopeptides. Synthesis and Biological Evaluation of Conformationally Restricted Glutathione Analogues 106
Totale 14.455
Categoria #
all - tutte 70.022
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 70.022


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021263 0 0 0 0 0 0 0 0 0 108 72 83
2021/2022749 32 22 10 74 88 33 36 50 103 33 70 198
2022/20232.378 177 358 155 258 212 451 114 216 281 47 54 55
2023/20241.295 97 66 72 47 63 409 273 70 20 22 25 131
2024/20253.166 161 584 519 119 42 188 111 177 255 156 354 500
2025/20266.421 544 289 572 803 639 383 1.055 381 1.280 475 0 0
Totale 19.057